Advances in photodynamic therapy and its combination strategies for breast cancer
Open Access
- 31 August 2025
- journal article
- review article
- Published by Elsevier in Acta Biomaterialia
- Vol. 205, 125-140
Abstract
No abstract availableKeywords
Funding Information
- Cancer Institute NSW
- National Health and Medical Research Council (2019/CDF1013)
This publication has 193 references indexed in Scilit:
- K2FeO4‐Enhanced Photodynamic Therapy of Breast Cancer via In Situ Synthesis of Fe2O3 and O2Advanced Healthcare Materials, 2024
- Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their NanodrugsAdvanced Materials, 2024
- Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma ChemotherapyAdvanced Materials, 2023
- Cancer models in preclinical research: A chronicle review of advancement in effective cancer researchAnimal Models and Experimental Medicine, 2021
- Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic ApplicationsAdvanced Materials, 2020
- Photosensitizers for Photodynamic TherapyAdvanced Healthcare Materials, 2019
- Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma TherapyAdvanced Science, 2019
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast CancerJAMA Oncology, 2019
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- In vivo light dosimetry for motexafin lutetium‐mediated PDT of recurrent breast cancerLasers in Surgery and Medicine, 2002